Therapeutics and Speciality Expertise

Meta-Works has assisted enterprises launch, manage and promote their therapeutics and services across many disease states in a wide array of markets. It has developed a reputation for rapid familiarisation of new products and the intricacies associated with new and existing markets.
Please see below for details on Evident’s breadth of drug experience in strategic therapeutic areas.


Health Technology Assessments on monoclonal antibodies, aromatase inhibitors, vinea alkaloids, other chemotherapies erythropoiesis stimulating agents, immune-suppressants, steroidal aromatase inactivators in the cancer focus areas of:


Systematic and Marketing reviews in the focus area of HIV on various antiretroviral medication including nucleoside reverse transcriptase inhibitors, protease inhibitors.


Feasibility assessment on new product registrations and extensions on:

  • blood pressure lowering drugs

  • heart failure and ventricula impairment


Reimbursement applications in actinic keratosis, solar keratosis & rosacea as:

  • Immune response modifiers

  • Sensitizers used in photodynamic/radiation therapy -ingenol mebutate

Obstetrics & Gynaecology

Regulatory & pricing applications in the focus areas of:

  • Contraceptive drugs & devices


Regulatory submissions, systematic reviews and reimbursement submissions on:

  • tetracyclic antidepressants

  • SSNRIs

Erectile Dysfunction

Health Technology Assessments and market reviews on:

  • prostaglandin

  • tadalafil

Rare Diseases

Global review of manufacturers’ incentives. Ultra/Orphan drug applications and regulatory submissionsin:


Systematic reviews in rheumatoid arthritis, Crohn’s disease, osteoarthritis, adrenocortical deficiency states of:

  • TNF inhibitors

  • adalimumab

  • COX-2 selective NSAIDs

  • chimeric monoclonal antibody

  • glucocorticoid


Literature-based submissions on macrocyclic lactone medicines in parasite infestations of:

  • Typical scabies

  • Crusted scabies

Wound Care

Reimbursement submissions on

  • medicated band aides

  • biosynthetic meshes

Coagulation Disorders

Orphan applications, literature- based submissions on recombinants, low molecular weight heparin, warfarin, rivaroxaban, dabigitran, edoxaban, apixaban, tranexamic acid in the focus areas of:

  • Glanzmann’s thrombasthenia

  • Factor VII deficiency

Pain Management

Regulatory and Pricing applications for:

  • oxycodone

  • fentanyl

  • buprenorphine

  • ibuprofen

  • paracetamol